Catalyst Wire Dossier Catalyst Wire Dossier

Dehypotin®

· Nang Kuang Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dehypotin®, covering 2011-06-09 to 2011-06-09. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating the Efficacy and Safety of Dehypotin® in the Patients With Type 2 Diabetes Mellitus or Cardiovascular Disease [Phase 4]

See pricing